Results 111 to 120 of about 105,569 (311)
C-type natriuretic peptide and vascular remodeling
Morishige et al. [(1)][1]have reported local adenovirus-mediated transfer of C-type natriuretic peptide (CNP) to porcine coronary arteries, resulting in reduced stenosis of balloon-injured segments. This is an exciting development with obvious therapeutic potential.
Davidson, Neil C, Struthers, A D
openaire +2 more sources
Abstract Heart failure (HF) creates a considerable clinical, humanistic and economic burden on patients and caregivers as well as on healthcare systems. To attenuate the significant burden of HF, there is a need for enhanced management of patients with HF.
Javed Butler +8 more
wiley +1 more source
Purpose: This study investigated the role of natriuretic peptide receptor 2 (NPR2) on cell proliferation and testosterone secre-tion in mouse Leydig cells.Materials and Methods: Mouse testis of different postnatal stages was isolated to detect the ...
Lei Yang +5 more
doaj +1 more source
Biomarkers in acute coronary syndromes and their role in diabetic patients [PDF]
Diabetic patients with acute coronary syndromes are at high risk for cardiovascular complications but risk stratification in these patients remains challenging.
Christopher Heeschen +5 more
core +1 more source
In this paper we have carried out the diagnosis of the damage of the vascular endothelium in patients with ischemic heart disease (IHD) based on the study of gene of endothelial nitric oxide synthase polymorphism, the condition of vasoregulating function
A. Kh. Akhmineeva +3 more
doaj
The severity of cardiovascular disease is linked to C-reactive protein, interleukin 6, and C-type natriuretic peptide levels, stressing the need for a sensitive sensor that can detect these biomarkers at ultralow levels in real time.
Ruxandra-Maria Ilie-Mihai +1 more
doaj +1 more source
Cardiac remodelling in the era of the recommended four pillars heart failure medical therapy
Abstract Cardiac remodelling is a key determinant of worse cardiovascular outcome in patients with heart failure (HF) and reduced ejection fraction (HFrEF). It affects both the left ventricle (LV) structure and function as well as the left atrium (LA) and the right ventricle (RV).
Giada Colombo +7 more
wiley +1 more source
The Role of Natriuretic peptides in Renovascular Hypertension and its correlation with the Evolution of Myocardial Hypertrophy [PDF]
The interactions between pressure and volume overload that occur in hypertension lead to different patterns of cardiac hypertrophy and to increase in natriuretic peptides (NPs).
Cavallero, Carmen Susana +4 more
core
Different behaviour of the N-terminal and C-terminal fragment of proatrial natriuretic factor in plasma of healthy subjects as well as of patients with cirrhosis [PDF]
N-terminal (atrial natriuretic factor (ANF) 1-98) and C-terminal (ANF 99-126) fragments of proatrial natriuretic factor (NTA and CTA, respectively) were determined in plasma of healthy subjects adopting different postures and in patients with cirrhosis ...
Arendt, Rainer M. +5 more
core +1 more source
C-Type Natriuretic Peptide and Cardiac Fibrosis [PDF]
See related article, pp 201–207 C-type natriuretic peptide (CNP), last of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and CNP to be discovered, has proven more difficult to investigate than its alphabetic predecessors, in part because circulating levels fall close to the limits of detection of immunoassays.
openaire +1 more source

